Novo Nordisk and Eli Lilly are facing scores of personal injury claims for allegedly failing to warn patients about side ...
In the United Kingdom, the government is hoping weight loss drugs might improve public finances, eyeing their use to help ...
A Goldman Sachs economist has suggested that the US economy could experience accelerated growth with increased use of GLP-1 ...
Despite the success of its new weight loss drug Zepbound, Lilly's recent earnings failed to meet expectations.
Ozempic, Wegovy and other GLP-1 drugs have been shown to curb alcoholism, a new study suggests. Researchers explain why diabetes and weight loss drugs work better than alcohol medications.